Rasmussen, Annika Læbo
Larsen, Søren Vinther
Ozenne, Brice
Köhler-Forsberg, Kristin
Stenbæk, Dea Siggaard
Jørgensen, Martin Balslev http://orcid.org/0000-0002-1321-8901
Giraldi, Annamaria
Frokjaer, Vibe G. http://orcid.org/0000-0002-9321-2365
Funding for this research was provided by:
Innovationsfonden (4108-00004B)
Lundbeckfonden (5189-00087A)
Det Frie Forskningsråd
Novo Nordisk Fonden (NNF21OC0068210)
Article History
Received: 11 February 2023
Revised: 24 June 2023
Accepted: 28 June 2023
First Online: 6 July 2023
Competing interests
: AG declares that she has served as a lecturer for Eli Lilly, Pfizer, Astellas, Viatris, and Lundbeck in addition to serving as a consultant for Eli Lilly as well as being on the advisory board of Futura Medical, OvacoBio, Pfizer, and FREYA Pharmaceuticals. Further, she states that she holds stocks in Novo Nordic. VGF declares that she has served as a consultant for H. Lundbeck and Sage Therapeutics.